ClinicalTrials.gg
Drug

Tolvaptan clinical trials

Also written Samsca, OPC-41061, Jinarc and OPC-156.

studies test it
89
open now
1
in phase 3
35
first study started
2002

How each study uses Tolvaptan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Tolvaptan studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
19 May 2009 · SAMSCA · NDA 022275 (FDA, Drugs@FDA)
European Union
2 Aug 2009 · Samsca · EMEA/H/C/000980 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Tolvaptan
63
OPC-41061(Tolvaptan)
3
Tolvaptan Oral Tablet
2
Tolvaptan MR
2
Tolvaptan IR
2

Brand

Samsca
34
Jinarc
3

Development codes

OPC-41061
21
OPC-156
2

Studies by the year they started

88 studies that test it; most in 2012 (13)

Studies that test Tolvaptan, by start year
YearStudies
20022
20033
20043
20051
20061
20076
20081
20095
20107
20119
201213
20135
20147
20156
20168
20172
20183
20192
20212
20221
20231

By phase

A phase 1/2 study counts in both.

Phase 1
9
Phase 2
25
Phase 3
35
Phase 4
18
No phase
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 55 · Other 34

Otsuka Pharmaceutical Development & Commercialization, Inc. (24) · Otsuka Pharmaceutical Co., Ltd. (19) · Otsuka Beijing Research Institute (7) · Regional Hospital Holstebro (4) · Korea Otsuka Pharmaceutical Co., Ltd. (3) · University of North Carolina, Chapel Hill (3) · Mario Negri Institute for Pharmacological Research (2) · Northwestern University (1)

Often tested with

Tested in the same studies.

Octreotide (1) · Chlorothiazide (1) · Midodrine (1) · Torsemide (1) · OPC-41601 (1)

Studies

Open first, then newest update. How each study uses Tolvaptan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 89

See all 89 studies that test Tolvaptan →

Given beside what is tested · 2 — Tolvaptan is usual care or a partner of the new treatment
As the comparator · 3 — what is tested is compared with Tolvaptan

Codes

What other systems call Tolvaptan · ClinicalTrials.gg INT006772

  • MeSH (NLM) D000077602TolvaptanConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 21G72T1950TOLVAPTANConfirmed FDA, NLM, Wikidata
  • RxNorm 358257Confirmed FDA, Wikidata
  • Wikidata Q426132tolvaptanConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C77082TolvaptanOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.